# A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects

> **NCT06506591** · PHASE1 · COMPLETED · sponsor: **Zhejiang Wenda Pharma Technology LTD.** · enrollment: 106 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** WD-890
- **DRUG:** WD-890 Tablets Placebo

## Key facts

- **NCT ID:** NCT06506591
- **Lead sponsor:** Zhejiang Wenda Pharma Technology LTD.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-26
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-08-15
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06506591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06506591, "A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06506591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*